ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCLP Scancell Holdings Plc

9.30
-0.10 (-1.06%)
03 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -1.06% 9.30 9.00 9.80 9.45 9.25 9.45 458,352 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.86M -0.0057 -16.49 97.46M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.40p. Over the last year, Scancell shares have traded in a share price range of 8.86p to 19.50p.

Scancell currently has 1,036,781,403 shares in issue. The market capitalisation of Scancell is £97.46 million. Scancell has a price to earnings ratio (PE ratio) of -16.49.

Scancell Share Discussion Threads

Showing 62076 to 62099 of 75475 messages
Chat Pages: Latest  2491  2490  2489  2488  2487  2486  2485  2484  2483  2482  2481  2480  Older
DateSubjectAuthorDiscuss
18/7/2023
06:43
Yep...like I said blaming others, not themselves.
Crumby blaming the company...TF blaming the fish....inane blaming PI's.
Everyone understands 44% inane...everyone. That's NOT the issue.
The issue is YOUR understanding of markets.
After all, you've only just worked out that humans aren't mice !

2tyke
18/7/2023
06:03
44% disease control rate (DCR) in ovarian cancer patients in ModiFY monotherapy trial

CD4 T cells work ........ now we know that technology exists that can improve that ...

do you really think that the checkpoint inhibitor Pharma who can't achieve any where near that are not going to be interested in some sort of tie up ...

the only choppy waters we are in is Pi unable to recognise Modi has worked

I appreciate the mouse model has not transferred like the immunobody mouse, however it is certainly not a failure

if the Ci achieved 44% it would be in phase 3 now .........

many are writing this off ... however for those that are buying and there are plenty ... stay tuned

Genmab as we have been told are very happy with data coming from there development and if they take it to trial will be a big lift to Glymab

inanaco
17/7/2023
21:52
Yep, they've feasted on promise....over-indulged....and now looking around to blame anyone but themselves.
2tyke
17/7/2023
21:45
Well, not much changes.

Nana and the club are now back in choppy waters. The club ties are burning and the blazers have long failed to fit the portly stature of the ever ageing personas.

aimbigger
17/7/2023
21:28
It's a dirty job guest speaking but somebody has to do it.

Because you dudes are gonna ask poor ol' Lindy....'what's happened to the stock price ?'
And Lindy gonna say...'I have no idea about the stock price'..because she's a honest lady.
And then I'm gonna get up and tell you like it is..
The questions you ask highlight the reason you've called this wrong.
They are all company issues.
There is nothing wrong with the company.
You just happen to think that the company is also a 'traded stock ticker'....and you're completely WRONG !

2tyke
17/7/2023
21:11
HOW wonderful that we will have you as a guest speaker 2tyke At THE agm do you have screen shot of your invite ?No doubt will you be brining your enlightening graphs on share price movements. , would interested to hear your take on
hxxps://www.wsj.com/articles/bear-market-from-cautionary-proverb-to-finance-lingo-11655416485
and also look for ward to your data on the following
Modi-1 44% of patients achieved stable disease for at least 8 weeks, with some patients experiencing a longer duration of disease stability for 4 months or more. Four patients are still ongoing in this cohort.
also your views on Scancell has developing pioneering technology platform for producing monoclonal antibodies that recognise glycans with high specificity and affinity. The platform has generated revenues and the antibodies continue to yield compelling results which have led to a new 6-month evaluation by a leading Biotech company. Additional in-house data has illustrated the potential of our antibodies as chimeric antigen receptor T cell (CART) therapies providing the data for a deal with a cell therapy company.

interesting that your so humble when you understand so much scientifically important first .
look forward to hearing from you with an intelligent honest response

cleanerworldwehope
17/7/2023
20:23
You should know what happens with company presentations in bear markets Chill.
Counter-productive.
Best wait for sentiment to turn.

2tyke
17/7/2023
20:15
I wonder when the Company did any investor presentations? Last one I remember was in Q4 last year.
chillpill
17/7/2023
20:12
Oh but they do read it count dracula .....obsessively so.
I'm not on the other bb.
I will tell it to their faces at the next AGM.
Apparently, I'm guest speaker.
They are cancelling all the nudge nudge wink wink and getting real next time !
Enjoy the education count....it's free at the moment.

2tyke
17/7/2023
19:46
2tyke,
If you've got something to say to someone on the other BB then say it there. Its insane behaviour to think they will read what you post here. Maybe you're just one of those that like talking behind someone's back?
Anyway... you've only been on here since last Monday, and obsessively so. All very strange indeed. Do you get a kick out of kicking someone when they're down while displaying your over inflated ego?

countbruga
17/7/2023
18:01
Wow...i've read some rubbish bb's, but the sclp LSE bb surely takes the biscuit !
Crumby is ready to sell the entire shop....for a quid...lol Deluded or what ?
Times like this eat away at your brain ! You can say that again. With some more than others.
Stocks fall much quicker than they rise. A long time to get back where it was.

2tyke
17/7/2023
17:51
Phoenix
You have a valid point regarding the former director and co founder of SCLP, Richard Goodfellow. He has 2.88 million options at 4.5p expiring at the end of this month. No mention was made of his options being extended when the announcement about Linda’s option being extended was made. I don’t know how many shares Goodfellow has or if he has funds available to exercise his options. If he doesn’t have the funds he would be mad not to sell shares he currently holds in order to take up the options. Even at today’s ridiculously low price he can still turn 100% profit in a day. Perhaps he has sold some in the last few days in order to do so.

888icb
17/7/2023
15:58
Yes...Marcus...completely and utterly adrift in markets.
He needs to be in a lab.
Forget markets !!

2tyke
17/7/2023
15:57
Lol...ee telling someone they are incompetent for selling.
You couldn't make it up !
Lollollollollollol.....

2tyke
17/7/2023
15:56
Again Marcus and his fairy tails. Keep on chatting the stories from SC website as the share price in a free fall. BS walks and so are you.
golcheja
17/7/2023
15:47
Phoenix ....everyone has a price where they'll rationalise losses and sell.
Except perhaps EE..,who prefers to drink in pubs with Kazakh directors lying through their teeth whilst he hangs onto every word.
He was warned.....in advance.

2tyke
17/7/2023
15:43
It’s a short term mess with lots of pain but should resolve itself in due course. Once selling is done….time to buy.
phoenixs
17/7/2023
15:42
Yes...such is the need for PI's to try and explain what doesn't need explaining as an 'event'....they are even prepared to roast the goose that they thought laid the golden eggs !!
2tyke
17/7/2023
15:41
My guess would be an offload from ex director who had options which are due to expire end of the month.
Those with very large holdings would not be selling. Cutting their nose to spite their face comes to mind. The biggest shareholders are in it for the long haul.

phoenixs
17/7/2023
15:39
Or EE...instead of making up stories after the event...
It could be a completely normal process within a bear market, that you were warned about ....in advance !!
Dear oh dear.
They're turning on the boss !
Told you they would.

2tyke
17/7/2023
15:25
Hi Kim !!!
Have you got anything 'interesting' to report dear ?
.............
Tosh don't be too hard on the car park man.
He was only as deluded as the other bulls !
Thought it was about science and data..
When it's actually about fear and greed ! And the way humans behave. All the time !

2tyke
17/7/2023
15:20
another day of carnage !

I don't know about a car park, but I do know that this is yet another car crash for a certain cretin.

tosh123
17/7/2023
15:06
What is pretty clear is that management has made a mess of things over the last couple of weeks. Major errors have been made - though it isn't yet clear what they are and neither is it clear whether they are important in the long term or not. Watch the main holders.....
markingtime
17/7/2023
15:02
Hope so, MT. Yes trials progressing and they are building knowledge in a valuable area. I recall LD mentioning offloading the whole immunobody dna platform not that long ago, and perhaps that strategy can advance further if good data is achieved. But she needs support - I imagine there is nothing more frustrating than trying and trying but no one is biting :)
wigwammer
Chat Pages: Latest  2491  2490  2489  2488  2487  2486  2485  2484  2483  2482  2481  2480  Older

Your Recent History

Delayed Upgrade Clock